Gemayel Georges
CIK 0001256088
Executive Chair of the BoardDirector
Filings
20
Latest Mar 9, 2026
Issuers covered
2
Showing
20 of 20
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 33% | +0.1% | -0.5% | +6.9% | -5.8% |
| 90 days | 6 | 33% | -1.9% | -7.3% | +18.9% | -16.2% |
| 180 days | 4 | 50% | +6.2% | +5.0% | +15.5% | -0.9% |
| 365 days | 4 | 0% | -33.3% | -33.9% | -24.0% | -41.4% |
Issuers
Companies where Gemayel Georges has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals, Inc. | 14 | Mar 9, 2026 |
| IRON | Disc Medicine, Inc. | 6 | Sep 18, 2025 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|